Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - September 2012

32nd European Peptide Symposium

02 Sep 2012 - 07 Sep 2012 - Athens, Greece

Bookmark and Share

The Symposium will take place at the Megaron Conference Center located in one of the nicest districts of Athens. Around 90 contributions have been selected for oral presentation, and the program will be announced by the end of June.

The Local Organizing Committee promises to offer the famous Greek hospitality to all participants. The social events will be announced later on. Visit Athens and enjoy science, social events, unique archeological sites, walks around Acropolis and the wonderful Greek weather.

Welcome address:

On behalf of the Organising Committee, we have the pleasure of inviting you to the 32nd European Peptide Symposium (32EPS 2012), which will be held in Athens from the 2nd to 7th September, 2012.

The symposium will present the most recent, cutting-edge research on a broad range of topics in the area of Peptide Science by leading international experts from both industry and academia. The scientific program will be structured around international invited speakers and oral presentations of selected high-quality submitted abstracts as well as poster sessions where all delegates are encouraged to present their data.

Athens, a bustling city of 5-million residents, is full of contrasts and pleasant surprises. The history of Athens is one of the longest of any city in Europe and in the world. Three thousand years old cultural riches are housed in approximately 50 national and private museums, including the new Acropolis museum, featuring from neolithic settlement finds to examples of modern art. When you are in Athens you will probably get the impression the city never sleeps.

It is our intention to establish an inspiring atmosphere for fruitful scientific discussions and for initiating new collaborations within and outside Europe.

We are looking forward to welcoming you in Athens at the 32nd European Peptide Symposium.

Prof. George Kokotos

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos